EUDA Health Holdings Ltd Financials

EUDA Health Holdings Ltd (EUDAW) reported $6.8M in total revenue for fiscal year 2025. This represents a 70.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

EUDA Health Holdings Ltd (EUDAW) revenue grew by 70% year-over-year, from $4.0M to $6.8M in fiscal year 2025.

No, EUDA Health Holdings Ltd (EUDAW) reported a net income of -$2.8M in fiscal year 2025, with a net profit margin of -40.6%.

EUDA Health Holdings Ltd (EUDAW) reported diluted earnings per share of $-1.48 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

EUDA Health Holdings Ltd (EUDAW) had EBITDA of -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

EUDA Health Holdings Ltd (EUDAW) had a gross margin of 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

EUDA Health Holdings Ltd (EUDAW) had an operating margin of -36.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

EUDA Health Holdings Ltd (EUDAW) had a net profit margin of -40.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

EUDA Health Holdings Ltd (EUDAW) generated -$2.5M in free cash flow during fiscal year 2025. This represents a -17.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

EUDA Health Holdings Ltd (EUDAW) generated -$2.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

EUDA Health Holdings Ltd (EUDAW) had $1.7M in total assets as of fiscal year 2025, including both current and long-term assets.

EUDA Health Holdings Ltd (EUDAW) invested $77K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

EUDA Health Holdings Ltd (EUDAW) invested $249 in research and development during fiscal year 2025.

EUDA Health Holdings Ltd (EUDAW) had 2M shares outstanding as of fiscal year 2025.

EUDA Health Holdings Ltd (EUDAW) had a current ratio of 0.18 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

EUDA Health Holdings Ltd (EUDAW) had a return on assets of -161.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, EUDA Health Holdings Ltd (EUDAW) had $345K in cash against an annual operating cash burn of $2.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

EUDA Health Holdings Ltd (EUDAW) has negative shareholder equity of -$4.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

EUDA Health Holdings Ltd (EUDAW) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

EUDA Health Holdings Ltd (EUDAW) has an earnings quality ratio of 0.88x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

EUDA Health Holdings Ltd (EUDAW) has an interest coverage ratio of -10.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

EUDA Health Holdings Ltd (EUDAW) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.